Patents by Inventor Francesco De Chiara

Francesco De Chiara has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MULTI-LAYERED CELL CAPSULES AND USES THEREOF
    Publication number: 20220151942
    Abstract: The present invention provides a hydrogel capsule comprising a cell, a protein, and a cross-linking agent; wherein the cell is within a first core layer comprising the protein; and wherein the first core layer is surrounded by a second layer comprising the protein and the cross-linking agent. The invention further provides the hydrogel capsule for use in therapy, prognosis and diagnosis, a method for culturing cells, a method for differentiating cells, and method for producing the hydrogel capsule.
    Type: Application
    Filed: February 3, 2022
    Publication date: May 19, 2022
    Inventors: Javier RAMÓN AZCÓN, Laura CLUA FERRÉ, Ferran VELASCO MALLORQUÍ, Maria Alejandra ORTEGA MACHUCA, Francesco DE CHIARA
  • Treatment of diseases associated with hepatic stellate cell activation using ammonia-lowering therapies
    Patent number: 11040021
    Abstract: Disclosed herein are methods of preventing, treating, and delaying the onset or progression of diseases associated with hepatic stellate cells (HSCs), such as non-alcoholic fatty liver disease (NAFLD), fibrosis, and liver cancer, using ammonia-lowering therapies.
    Type: Grant
    Filed: January 2, 2020
    Date of Patent: June 22, 2021
    Assignee: UCL BUSINESS LTD
    Inventors: Rajiv Jalan, Rajeshwar Prosad Mookerjee, Krista Rombouts, Fausto Andreola, Francesco De Chiara, Karen Louise Thomsen
  • TREATMENT OF DISEASES ASSOCIATED WITH HEPATIC STELLATE CELL ACTIVATION USING AMMONIA-LOWERING THERAPIES
    Publication number: 20200206175
    Abstract: Disclosed herein are methods of preventing, treating, and delaying the onset or progression of diseases associated with hepatic stellate cells (HSCs), such as non-alcoholic fatty liver disease (NAFLD), fibrosis, and liver cancer, using ammonia-lowering therapies.
    Type: Application
    Filed: January 2, 2020
    Publication date: July 2, 2020
    Inventors: Rajiv Jalan, Rajeshwar Prosad Mookerjee, Krista Rombouts, Fausto Andreola, Francesco De Chiara, Karen Louise Thomsen
  • Treatment of diseases associated with hepatic stellate cell activation using ammonia-lowering therapies
    Patent number: 10525029
    Abstract: Disclosed herein are methods of preventing, treating, and delaying the onset or progression of diseases associated with hepatic stellate cells (HSCs), such as non-alcoholic fatty liver disease (NAFLD), fibrosis, and liver cancer, using ammonia-lowering therapies.
    Type: Grant
    Filed: July 3, 2018
    Date of Patent: January 7, 2020
    Assignee: UCL BUSINESS LTD
    Inventors: Rajiv Jalan, Rajeshwar Prosad Mookerjee, Krista Rombouts, Fausto Andreola, Francesco De Chiara, Karen Louise Thomsen
  • TREATMENT OF DISEASES ASSOCIATED WITH HEPATIC STELLATE CELL ACTIVATION USING AMMONIA-LOWERING THERAPIES
    Publication number: 20190070142
    Abstract: Disclosed herein are methods of preventing, treating, and delaying the onset or progression of diseases associated with hepatic stellate cells (HSCs), such as non-alcoholic fatty liver disease (NAFLD), fibrosis, and liver cancer, using ammonia-lowering therapies.
    Type: Application
    Filed: July 3, 2018
    Publication date: March 7, 2019
    Inventors: Rajiv Jalan, Rajeshwar Prosad Mookerjee, Krista Rombouts, Fausto Andreola, Francesco De Chiara, Karen Louise Thomsen
  • Treatment of diseases associated with hepatic stellate cell activation using ammonia-lowering therapies
    Patent number: 10039735
    Abstract: Disclosed herein are methods of preventing, treating, and delaying the onset or progression of diseases associated with hepatic stellate cells (HSCs), such as non-alcoholic fatty liver disease (NAFLD), fibrosis, and liver cancer, using ammonia-lowering therapies.
    Type: Grant
    Filed: November 23, 2015
    Date of Patent: August 7, 2018
    Assignee: UCL BUSINESS PLC
    Inventors: Rajiv Jalan, Rajeshwar Prosad Mookerjee, Krista Rombouts, Fausto Andreola, Francesco De Chiara, Karen Louise Thomsen
  • TREATMENT OF DISEASES ASSOCIATED WITH HEPATIC STELLATE CELL ACTIVATION USING AMMONIA-LOWERING THERAPIES
    Publication number: 20170354627
    Abstract: Disclosed herein are methods of preventing, treating, and delaying the onset or progression of diseases associated with hepatic stellate cells (HSCs), such as non-alcoholic fatty liver disease (NAFLD), fibrosis, and liver cancer, using ammonia-lowering therapies.
    Type: Application
    Filed: November 23, 2015
    Publication date: December 14, 2017
    Inventors: Rajiv Jalan, Rajeshwar Prosad Mookerjee, Krista Rombouts, Fausto Andreola, Francesco De Chiara, Karen Louise Thomsen